Sugi Predict

Sugi Predict / Compounds / SCHEMBL12195367

SCHEMBL12195367

SCHEMBL12195367

CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC)OC(=O)CCCCCCCCCCCCCCCCC

nearest known ligand 0.79

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ LPAR3 Q9UBY5 7/20 0.79
▸ LPAR1 Q92633 4/20 0.79
▸ ENPP2 Q13822 7/20 0.78
▸ SMN1; SMN2 Q16637 1/20 0.78
▸ FABP3 P05413 1/20 0.74
▸ LPAR2 Q9HBW0 2/20 0.72
▸ ALDH1A1 P00352 1/20 0.71
▸ LMNA P02545 1/20 0.71
▸ SMPD1 P17405 1/20 0.68
▸ SELP P16109 1/20 0.65
▸ PLCG2 P16885 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28671483 1.00 LPAR3 (0.79) LPAR3LPAR1ENPP2SMN1; SMN2FABP3
SCHEMBL14984104 1.00 LPAR3 (0.79) LPAR3LPAR1ENPP2SMN1; SMN2FABP3
SCHEMBL21249160 1.00 LPAR3 (0.79) LPAR3LPAR1ENPP2SMN1; SMN2FABP3
SCHEMBL17232172 0.96 LPAR3 (0.85) LPAR3LPAR1ENPP2SMN1; SMN2FABP3
SCHEMBL19787880 0.95 LPAR3 (0.72) LPAR3LPAR1ENPP2SMN1; SMN2FABP3
SCHEMBL23225826 0.93 SELP (0.76) LPAR3LPAR1ENPP2SMN1; SMN2FABP3
SCHEMBL40543 0.93 SELP (0.76) LPAR3LPAR1ENPP2SMN1; SMN2FABP3
SCHEMBL21641458 0.93 SELP (0.76) LPAR3LPAR1ENPP2SMN1; SMN2FABP3
SCHEMBL40542 0.93 SELP (0.76) LPAR3LPAR1ENPP2SMN1; SMN2FABP3
SCHEMBL2622733 0.93 SELP (0.76) LPAR3LPAR1ENPP2SMN1; SMN2FABP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260117071-A1 ICG LIPID DERIVATIVE, AND LIPID MICROPARTICLES EACH CONTAINING SAME NATIONAL UNIVERSITY CORPORATION HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE (JP) 2026-04-30 — — US disclosed
EP-4516797-A1 ICG LIPID DERIVATIVE, AND LIPID MICROPARTICLES EACH CONTAINING SAME Eisai R&D Management Co., Ltd. (JP) 2025-03-05 — — EP disclosed
CN-119183454-A ICG lipid derivatives and lipid-based particles comprising the same 卫材R&D管理有限公司 2024-12-24 — — CN disclosed
US-9770520-B2 Chelate nanoemulsion for MRI GUERBET (FR) 2017-09-26 — — US disclosed
US-9770520-B2 Chelate nanoemulsion for MRI GUERBET (FR) 2017-09-26 — — US disclosed
US-20130309176-A1 CHELATE NANOEMULSION FOR MRI UNIVERSITE DE BORDEAUX 1 (FR) 2013-11-21 — — US disclosed
US-20110243859-A1 ENCAPSULATING SYSTEM FOR CEST IMAGING WITH CHELATE Q GREATER THAN OR EQUAL TO 2 GUERBET (FR) 2011-10-06 — — US disclosed
US-20110243859-A1 ENCAPSULATING SYSTEM FOR CEST IMAGING WITH CHELATE Q GREATER THAN OR EQUAL TO 2 GUERBET (FR) 2011-10-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130309176-A1 CHELATE NANOEMULSION FOR MRI SGMS1, SGMS2, PHOSPHO1 LPAR3 15/4885LPAR1 57/4885ENPP2 372/4885
US-20260117071-A1 ICG LIPID DERIVATIVE, AND LIPID MICROPARTICLES EACH CONTAINING SAME LDLR, CHMP4B, CETP LPAR3 53/4885LPAR1 63/4885ENPP2 1695/4885
US-20110243859-A1 ENCAPSULATING SYSTEM FOR CEST IMAGING WITH CHELATE Q GREATER THAN OR EQUAL TO 2 QPCT, ESYT2, QPCTL LPAR3 3902/4885LPAR1 3928/4885ENPP2 295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.